These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8825880)

  • 1. Further investigations into the mechanism of antifibrillatory action of the specific IK1 blocker, RP58866, assessed using the rat dual coronary perfusion model.
    Rees SA; Curtis MJ
    J Mol Cell Cardiol; 1995 Dec; 27(12):2595-606. PubMed ID: 8825880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate.
    Rees SA; Curtis MJ
    Circulation; 1993 Jun; 87(6):1979-89. PubMed ID: 8504513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
    Curtis MJ; Garlick PB; Ridley PD
    J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-arrhythmic protection by ischaemic preconditioning in isolated rat hearts is not due to depletion of endogenous catecholamines.
    Lawson CS; Hearse DJ
    Cardiovasc Res; 1996 Apr; 31(4):655-62. PubMed ID: 8689659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
    Farkas A; Qureshi A; Curtis MJ
    Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of microcirculation by coloured microspheres and NMR-microscopy in isolated rat heart: effect of ischaemia, endothelin-1 and endothelin-1 antagonist BQ 610.
    Hiller KH; Roder F; Adami P; Voll S; Kowallik P; Haase A; Ertl G; Bauer WR
    J Mol Cell Cardiol; 1997 Nov; 29(11):3115-22. PubMed ID: 9405185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
    Xu D; Zhang S; Foster DJ; Wang J
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism.
    Baker KE; Curtis MJ
    Br J Pharmacol; 2004 May; 142(2):352-66. PubMed ID: 15066909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
    Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
    Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-arrhythmic effects of levcromakalim in the ischaemic rat heart: a dual mechanism of action?
    Coetzee WA; Wells T; Avkiran M
    Eur J Pharmacol; 2000 Aug; 402(3):263-74. PubMed ID: 10958894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation block of the HERG human cardiac K+ channels by RP58866.
    Wang H; Shi H; Wang Z
    Br J Pharmacol; 1999 Aug; 127(8):1899-907. PubMed ID: 10482922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels.
    Friedrichs GS; Chi L; Black SC; Manley PJ; Oh JY; Lucchesi BR
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1348-54. PubMed ID: 8371141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of RP58866 on transmembrane K+ currents in mammalian ventricular myocytes.
    Yang BF; Li GR; Xu CQ; Nattel S
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):961-9. PubMed ID: 11270975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
    Baker KE; Curtis MJ
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):394-401. PubMed ID: 10470998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes.
    Brandts B; Van Bracht M; Tüttelmann F; Allessie MA; Trappe HJ
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1812-5. PubMed ID: 11139931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.